Streetbeat News

Revenues

VZIO

VIZIO Holding (NYSE:VZIO) reported Q2 sales of $437.3 million, surpassing the analyst consensus estimate of $398.31 million by 9.79%. This marks a 10.88% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:21 pm

ASTH

Astrana Health (NASDAQ:ASTH) reported Q2 2024 earnings per share (EPS) of $0.40, missing the analyst consensus estimate of $0.41 by 2.44%. However, the company reported quarterly sales of $486.265 million, beating the analyst consensus estimate of $440.752 million by 10.33%. This represents a 39.65% increase over sales of $348.209 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:21 pm

MRVI

Maravai LifeSciences (NASDAQ:MRVI) reported Q2 sales of $73.4 million, surpassing the analyst consensus estimate of $71.634 million by 2.46%. This marks a 6.51% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:20 pm

GWRS

Global Water Resources reports a significant increase in organic growth, with active connections rising by 4.9% year over year, compared to 1.9% in the same period in 2023.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:20 pm

UVV

Universal Corporation expects continued strong demand to support solid results for its Tobacco Operations segment for FY25. The company anticipates that tobacco shipment timing and related revenue recognition will be more heavily weighted towards the second half of fiscal year 2025.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:19 pm

RDW

Redwire (NYSE:RDW) reported Q2 sales of $78.100 million, surpassing the analyst consensus estimate of $68.382 million by 14.21%. This marks a 29.95% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:17 pm

LSF

Laird Superfood (AMEX:LSF) reported Q2 2024 adjusted EPS of $(0.03), beating the analyst estimate of $(0.11) by 72.73%. The company also reported sales of $10.000 million, surpassing the $9.314 million estimate and marking a 29.47% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:17 pm

LYEL

Lyell Immunopharma (NASDAQ:LYEL) reported Q2 losses of $(0.18) per share, beating the analyst estimate of $(0.20). However, sales dropped to $13.00K from $27.00K YoY.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:17 pm

VOXR

Vox Royalty Corp. has estimated its royalty revenue to be between $11 million and $13 million, which is unchanged from its prior guidance.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:17 pm

NDLS

Noodles (NASDAQ:NDLS) reported Q2 2024 adjusted EPS of $(0.05), meeting analyst expectations. However, sales of $127.352 million missed the $130.697 million estimate by 2.56%, though they increased by 1.76% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:17 pm